← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Treovir, Inc
Birmingham, AL
$2,001,622
Total funding
1
Grants
Funding over time
peak $1.1M · FY2020–23$2M$1.5M$1M$500K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,001,622 · 1
By mechanism
R44$2,001,622 · 1
Investigators at Treovir, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas$890,765
R44 · FY2023 · CA
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas$611,912
R44 · FY2020 · CA
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas$497,320
R44 · FY2020 · CA
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas$1,625
R44 · FY2022 · CA